News for Rhythm Biosciences Limited (RHY.AX)

Medical diagnostics company Rhythm Biosciences (ASX: RHY) has confirmed that the second version of its ColoSTAT kit for the detection of colorectal cancer

Rhythm BioSciences (ASX:RHY) has announced it is progressing with its entry of ColoSTAT into the United Kingdom.

A handy updraft from US and Japanese markets helped the Australian bourse record its second consecutive rise.

The ASX 200 closed lower today, falling 0.49 per cent to close at 7199.2 points. It came after the ABS revealed wage prices are still too high.

Rhythm Biosciences (ASX:RHY) has gained regulatory approval for its colon cancer detection blood test in the United Kingdom.

Australian shares finished lower ahead of US inflation data announcements, with hopes the Federal Reserve will resist rate hikes in the coming months.

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

The local share market has finished basically unchanged, with gains for mining companies balances by losses elsewhere.

The ASX 200 burst through the doors this morning like it was halfway through a pub crawl in a small town with 100 pubs. All over the shop.

Control Bionics launched the world's first autonomous driving wheelchair, DROVE at Deakin University’s new Digital Health Lab.

Global markets and ASX show resilience in March as gold stocks the beneficiary of rising gold prices as investors seek safe havens.

The ASX has staged The Recovery We Had To Have this morning, but the lukewarm +0.3% was waaay behind Vita Group's ball-busting 72% screamer.

Rise and Shine: Everything you need to know before the ASX opens

The ASX has finished lower for the week, after both Materials and Energy were brutalised while markets shook, both here and abroad.

Uranium going cheap - well, under $20 million, Tesla's rare earths stocks destroying bombshell, and Australia's rental market halving crisis.

RooLife got the party jumping +112%, the benchmark gassed out an hour before close and Harris broke up with Credit Suisse. About time, too.

RooLife's got the Remedy for success, and there's been a 6.7% spike in Japan’s key Living with Parents’ Corpses Index (LPCI).

On Stockhead today, It's the flight from flight as we explore the secret sector of stocks about to benefit from Aussie Air Travel Anger.

ABS data restarted the market's heart today, driving the ASX to a 0.1% gain after what looked like a terminal drop at the start of the session.